Login / Signup

Infliximab improved the refractory cutaneous involvement in a patient with dermatomyositis.

Saori Kanazawa-YamadaIkko KajiharaAtsuko KobayashiChinatsu WatanabeHironobu Ihn
Published in: Dermatologic therapy (2019)
Keyphrases
  • interstitial lung disease
  • case report
  • disease activity
  • ulcerative colitis
  • systemic lupus erythematosus
  • idiopathic pulmonary fibrosis